This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth's (UNH) Suffering Continues: Should You Hold Tight?
by Zacks Equity Research
Each sub-segment of Optum, UnitedHealth's (UNH) health service business, is expected to continue delivering a solid performance, driving the overall segment's growth.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $477.88 in the latest trading session, marking a -0.57% move from the prior day.
These 3 Companies Are Cash-Generating Machines
by Derek Lewis
A company displaying free cash flow strength has freedom for growth opportunities, can consistently shell out dividends, and wipe out debt easily.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $482.56, moving +0.73% from the previous trading session.
Factors That Make HCA Healthcare (HCA) a Lucrative Bet Now
by Zacks Equity Research
HCA Healthcare (HCA) remains well-poised for growth on the resumption of elective surgeries, acquisitions and strong cash-generation abilities.
UnitedHealth Group (UNH) Expands Home Healthcare Business
by Zacks Equity Research
UnitedHealth Group (UNH) boosts home healthcare presence with the acquisition of Amedisys for $3.3 billion
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
UnitedHealth's (UNH) Optum Rx Makes Patient Care Affordable
by Zacks Equity Research
UnitedHealth Group, Inc's. (UNH) Optum Rx is set to offer three biosimilar alternatives for HUMIRA effective Jul 1, providing affordability in patient care.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $476.75, marking a +1.57% move from the previous day.
UnitedHealth's (UNH) Program to Aid Georgia's Diabetic Patients
by Zacks Equity Research
UnitedHealth's (UNH) unit, UnitedHealthcare, extends its community-based program to improve the health conditions of Southwest Georgia's diabetic patients.
U.S. Health Insurers Are Tumbling: Should You be Worried?
by Kaibalya Pravo Dey
Demand for procedures like hip and knee surgeries is rising, which will leave fewer premiums in hand after paying for the procedures for the health insurers.
Humana (HUM) Sees Insurance Costs at Upper Limit of Guidance
by Zacks Equity Research
Despite the rising demand for elective procedures, Humana (HUM) sticks to its earnings guidance.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
UnitedHealth (UNH) Falls 6.4% on Cost Woes of Resumed Surgeries
by Zacks Equity Research
UnitedHealth's (UNH) Optum Health unit is likely to witness higher utilization, especially in ambulatory surgery operations.
Universal Health (UHS) Gains 3.7% as Pent-Up Surgeries Rise
by Zacks Equity Research
The pent-up demand for elective surgeries is expected to improve Universal Health's (UHS) patient admissions and patient days.
Company News for Jun 15, 2023
by Zacks Equity Research
Companies in The News Are: UNH, AMD, AMZN, UHS, DVN
The Zacks Analyst Blog Highlights Apple, UnitedHealth, Eli Lilly, Walmart and Becton, Dickinson
by Zacks Equity Research
Apple, UnitedHealth, Eli Lilly, Walmart and Becton, Dickinson are part of the Zacks top Analyst Blog.
Top Stock Reports for Apple, UnitedHealth & Eli Lilly
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), UnitedHealth Group Incorporated (UNH) and Eli Lilly and Company (LLY).
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $492.59, moving -0.21% from the previous trading session.
The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson Controls International, Casey's General Stores and TotalEnergies
by Zacks Equity Research
UnitedHealth Group, Johnson Controls International, Casey's General Stores and TotalEnergies are part of the Zacks top Analyst Blog.
4 Stocks to Watch on Dividend Hikes as Economic Worries Worsen
by Ritujay Ghosh
UnitedHealth Group Incorporated (UNH), Johnson Controls International plc (JCI), Casey's General Stores, Inc. (CASY) and TotalEnergies SE (TTE) hike dividends.
Zacks Industry Outlook Highlights UnitedHealth Group, The Cigna Group, Humana, Centene Corporation and Molina Healthcare
by Zacks Equity Research
UnitedHealth Group, The Cigna Group, Humana, Centene Corporation and Molina Healthcare are part of the Zacks Industry Outlook article.
UnitedHealth Group (UNH) Hikes Quarterly Dividend by 14%
by Zacks Equity Research
UnitedHealth Group's (UNH) recent dividend hike highlights a solid financial position and efforts to sustain its sound capital deployment history.
5 HMO Industry Stocks to Watch as Technology Expenses Take a Toll
by Debasmita Chatterjee
The Medical-HMO industry is witnessing growth in customer base and an active M&A strategy. However, high technology expenses and medical personnel shortage raise concerns. UNH, CI, HUM, CNC and MOH are likely to navigate the industry storms.